Selected Publications

Kim DW, Wu N et. al (2016). Genetic requirement for Mycl and efficacy of RNA Pol I inhibition in mouse models of small cell lung cancer. Genes and Development. 2016. 30(11): 1289-99. doi:10.1101/gad.279307.116.

Denny SK, Yang D, et. al (2016). Nfib promotes metastasis through a widespread increase in chromatin accessibility. Cell. 2016. Jun 29. pii: S0092-8674(16)30655-9.

George J, Lim JS, et al. Comprehensive genomic characterization of small cell lung cancer. Nature. 2015. 524(7363):47-53.

Jahchan N, et al. A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors. Cancer Discovery. 2013. 3(12): 1364-77.

Peifer M et al. Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer.Nature Genetics. 2012. 44(10):1104-10.

Park K, Martelotto L, et al. A crucial requirement for Hedgehog signaling in small cell lung cancer. Nature Medicine. 2011.17(11): 1504-8.

Schaffer B, Park K, et. al. Loss of p130 accelerates tumor development in a mouse model for human small-cell lung carcinoma. Cancer Research. 2010. 70(10): 3877-83.